Biography

Dr Anand Shah is a consultant respiratory physician based at the Royal Brompton Hospital. He has expertise in infection, particularly fungal lung infection and bronchiectasis. 

Dr Shah qualified with his medical degree from Imperial College London before training in respiratory medicine. He spent time in the lung transplant unit at Harefield Hospital and the Host Defence Unit at Royal Brompton Hospital, where he developed an interest in fungal lung infection. 

Dr Shah was awarded a Medical Research Council Clinical Research Training Fellowship in 2011 for research investigating the susceptibility to fungal infection in solid organ transplantation at Imperial College London.  His work earned him a PhD and a number of publications.

Dr Shah became a consultant at Royal Brompton and Harefield hospitals in 2016, looking after patients with complex respiratory infection. He leads the fungal clinical service, one the largest complex lung fungal patient services in Europe. 

Areas of expertise

Dr Shah is a respiratory consultant with an expertise in infection and, in particular, fungal lung infection. These include patients with: 

• Respiratory infection
• Fungal lung infection (including aspergillosis)
• Host defence abnormalities
• Bronchiectasis
• COVID-19 (infection and long-COVID)
• Cystic fibrosis
• Primary ciliary dyskinesia
• Primary or secondary immunodeficiency
• Non-tuberculous mycobacteria.
• Asthma and allergic bronchopulmonary aspergillosis

Research and teaching

Dr Shah has ongoing active research interests in a number of fields. He focuses particularly on improving outcomes in bronchiectasis, respiratory infection with a particular focus on antimicrobial resistance and fungal lung disease. 

Dr Shah has received the prestigious Medical Research Council Clinical Academic Research Partnership Award and further grants from Medical Research Council, Wellcome Trust and other funders. 

Dr Shah's research areas of interest include: 

• Targeting Immunotherapy for Fungal Infections in Cystic Fibrosis (TrIFIC)
• Fungal Resistance Evolution and Acquisition in chronic Lung disease (FREAL)
• Evaluating tablet and web-based audiometry to detect and monitor hearing loss in cystic fibrosis
• Developing remote capillary blood testing to monitor chronic lung disease
• Use of deep learning to develop automated CT quantification in chronic pulmonary aspergillosis
• Antimicrobial resistance
• Impact of Chronic Pulmonary Aspergillosis (CPA) on health status and wellbeing
• Impact of viral infection in chronic lung disease 
• Effect of microbial dysbiosis upon anti-viral Immunity in bronchiectasis

Dr Shah is a senior lecturer at Imperial College London. He has an active translational research laboratory where he supervises a number of PhD students and leads multiple national and international research programmes. 

Dr Shah is a co-director of the Imperial College Fungal Research Network of Excellence and chairs the European Respiratory Society Antimicrobial Resistance Lung network (AMR-Lung), with over 300 members across 60 countries.

Awards

• Medical Research Foundation - Skills and development award 2022
• MRC Clinical Academic Research Partnership award - 2019
• CF Trust Venture Innovation award - 2019
• Vertex Research Innovation award - 2018
• Gilead Invasive Fungal Infection fellowship award - 2018
• CF Trust Clinical Excellance and Innovation award - 2017
• Darzi Fellowship in Clinical Leadership (Sponsor) - 2017 and 2018
• MRC Clinical PhD Research Fellowship - 2012